Achieve Life Sciences enters agreement with Jefferies for up to $150 million at-the-market stock offering
ACHV•At-the-market equity agreement with Jefferies
Achieve Life Sciences entered an at-the-market equity distribution agreement with Jefferies for up to $150 million of common stock.
Jefferies will act as sales agent, using commercially reasonable efforts, with a commission of up to 3% of gross proceeds.
Proceeds are targeted for cytisinicline commercialization, funding a Phase 3 e-cigarette cessation trial, working capital, and general corporate purposes.
